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Abstract
The micro-array profiling of micro-RNA has been performed in rat skeletal muscle tissues, isolated from male adult offspring
of intrauterine plus postnatal growth restricted model (IPGR). Apparently, the GLUT4 mRNA expression in male sk. muscle
was found to be unaltered in contrast to females. The over-expression of miR-29a and miR-23a in the experimental group of
SMSP (Starved Mother Starved Pups) have been found to regulate the glucose transport activity with respect to their control
counterparts CMCP (Control Mother Control Pups) as confirmed in rat L6 myoblast-myocyte cell culture system. The ex-vivo
experimentation demonstrates an aberration in insulin signaling pathway in male sk. muscle that leads to the localization of
the membrane-bound Glut4 protein. We have identified through a series of experiments one important protein factor
SMAD4, a co-SMAD critical to the TGF-beta signaling pathway. This factor is targeted by miR-29a, as identified in an in vitro
reporter-assay system in cell-culture experiment. The other micro-RNA, miR-23a, targets SMAD4 indirectly that seems to be
critical in regulating insulin-dependent glucose transport activity. MicroRNA mimics, inhibitors and siRNA studies indicate
the role of SMAD4 as inhibitory for glucose transport activities in normal physiological condition. The data demonstrate for
the first time a critical function of microRNAs in fine-tuning the regulation of glucose transport in skeletal muscle. Chronic
starved conditions (IPGR) in sk. muscle up-regulates microRNA changing the target protein expression patterns, such as
SMAD4, to alter the glucose transport pathways for the survival. The innovative outcome of this paper identifies a critical
pathway (TGF-beta) that may act negatively for the mammalian glucose transport machinery.
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Introduction
Tissue-specific, developmental and stress-induced expression
patterns of a group of microRNAs regulate essential functions in
biological systems [1–3]. These small RNA elements are powerful
post-transcriptional regulators in altering gene expression to
orchestrate the normalization of physiological activities under
stress conditions. Thus, it is likely that aberrant expression of
microRNA leads to disease conditions including carcinogenesis
and metabolic syndromes. The glucose transporters in peripheral
tissues, such as skeletal muscles, are pivotal in regulating glucose
transport activity and thus balance glucose homeostasis in the
blood. In response to insulin, ischemia and exercise, GLUT4
molecules translocate into the plasma membrane and orchestrate
facilitative glucose transport into the cells [4]. Insulin-dependent
translocation of GLUT4 vesicles into the plasma membrane is the
major mechanism by which glucose uptake into the sk. muscles
and cardiac muscle tissues can be often regulated [5,6]. Aberration
in skeletal muscle glucose transport pathway can cause metabolic
diseases including insulin resistance and diabetes [7–12]. Groups
of tissue-specific (e.g., miR-1, miR-206, miR-208) and non-tissue-
specific (e.g., miR-29a, miR-23a) microRNAs have been found to
control skeletal muscle development in growth and differentiation
[13–19]. The tissue-specific microRNAs can regulate glucose
homeostasis and the pathophysiology of metabolic disease [20–
22]. The expression of GLUT4, both transcriptional and
translational, and its membrane trafficking from cytoplasmic
vesicles upon insulin signaling, is critical in glucose transport
activity of sk. muscles in both normal physiological and metabolic
disease conditions [23–26]. Intrauterine growth restriction (IUGR)
model mediated by various causes (e.g., semi-calorie food
restriction, protein restriction, hypoxic condition in rodents) has
been shown to alter the insulin signaling in offspring, leading to the
development of insulin resistance in the sk. muscles [27–31]. The
transcriptional changes of GLUT4 expression in female rat under
these conditions has been attributed to the epigenetic changes
including histone modifications, histone deacetylation (HDAC
recruitment) and other associated changes in key enzymes of this
process [32]. The histone code modifications were also been
inferred in IGF1 transcription of IUGR rat offspring in
programmed obesity [33]. The inappropriate nutrition in the
early intrauterine growth phase can have a deleterious effect on
the adult life, such as metabolic syndrome [34]. All of these
observations raise the possibility of trans-generational epigenetic
changes that may have occurred in the intrauterine environment
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susceptible to the development of phenotype leading to metabolic
disorders. While investigating the GLUT4 status of the male
counterpart skeletal muscle, no change was observed in total
GLUT4 expression overall in comparison to the female counter-
part in IPGR offspring. This differential, gender-specific tran-
scriptional control of GLUT4 under this food restriction protocol
led me to investigate the global microRNA gene expression
pattern in male sk. muscles and thus the involvement of these small
regulatory genetic elements in the glucose transport process. MiR-
223 and miR-133 regulate the expression of glucose transporter 4
in cardiomyocytes either by directly targeting GLUT4 39UTR or
indirectly targeting other protein-coding mRNA, e.g., KLF15
[35,36]. MiR-223 up-regulation in cardiomyocytes causes the
phosphatidylinositol-3-kinase (PI-3K) independent increase of
glucose transport activity [36]. The miR-29 group of microRNAs
was found to be up-regulated in muscle and fat tissues of Goto–
Kakizaki rats, a non-obese rat model of diabetes mellitus (T2DM).
The over-expression of miR-29 in 3T3-L1 adipocytes inhibited
insulin-stimulated glucose uptake [37].
The cutting edge LNA-based microarray of microRNA in male
skeletal muscle revealed a number of microRNAs were up- and
down-regulated in the experimental SMSP (Starved Mother
Starved Pup; Semi-calorie food-restriction model) animal offspring
compare to CMCP. I began investigating the functional
significance of these microRNAs in regulating the glucose
transport activity in a rat cell culture system. MicroRNA 29a
and 23a proved to be significant in fine-tuning glucose transport
activity in an insulin-independent and dependent manner,
respectively. Finally, an effort was made to discover some of the
regulatory components of this essential functional glucose
transport activity in sk. muscle targeted by specific microRNA(s).
I revealed the observation that SMAD4 (mothers against
decapentaplegic homolog 4), a co-SMAD of the TGF-b pathway,
may play a significant role in linking the core metabolic pathway
with skeletal muscle growth and differentiation.
Materials and Methods
Antibodies, LNA-based Pre-miR(s), anti-miR(s) inhibitors,
siRNA(s)
The antibodies used for Western Blot analysis are Glut4
(Abcam, ab654), Glut3 (made in Devaskar’s lab, UCLA), Glut1
(Abcam, ab15309), IGFR (Cell Signaling, 111A9), EGFR,
(Santacruz, sc 03, 1005), Glucose-6-P dehydrogenase (Abcam,
ab34436), Protein Kinase C-zeta (Cell signaling, ab51157), P-
PKC-zeta (Abcam, ab76129), Syntaxin 4 (Abcam, ab57841),
Vamp2 (Abcam, ab3347), Vimentin (Santacruz, sc73259, Actin
(Santacruz, sc-1615), Nucleolin (Santacruz, sc13057), Lamin A
(Santacruz, sc-20680), MEF2C (Abcam, ab65252), HDAC4 (Cell
Signaling, #2072), HAND2 (Abcam, ab56590), Tropomyosin C
(Santacruz, sc73225), DnaJB1 (Santacruz, sc-1800) and SMAD4
(Abcam, ab1341). Precursor microRNA mimics- Mimics of endogenous
precursor micro-RNA synthetic molecule for rat, namely, Pre-
miR-1, Pre-miR-23a, Pre-miR-23b and Pre-miR-29a were
purchased from Ambion Inc. for gain-of-function studies in the
rat cell-culture system. Pre-miR
TM miRNA Precursor (AM17110)
is a double-stranded RNA oligonucleotide designed to serve as a
negative control for experiments involving Pre-miR miRNA
precursors. Anti-miR(s) inhibitors - miRCURY LNA
TM microRNA
Inhibitors are pre-designed microRNA inhibitors with a novel
design by Exiqon Inc. The micro-RNA inhibitors have been
optimized with respect to potency and stability against each of the
ready-made LNA-based anti-sense oligonucleotides. siRNAs have
been used from Dharmacon SMARTpool system. DharmaFECT
transfection reagent was used for siRNA experiment.
Animal
Sprague-Dawley rats (Charles River Breeding Laboratories,
Hollister, CA) were housed separately in cages, exposed to 12:12-
hour light-dark cycles at 21–23uC, and allowed ad libitum access to
standard rat chow. Animal care was approved by the Animal
Research Committee at UCLA in accordance with the guidelines
from the NIH, Bethesda, Maryland. The skeletal muscle tissues
were given to the author for this in vitro study. The author did not
raise the animals for in vivo studies. The maternal semi-nutrient
restriction model and the postnatal animal maintenance were
detailed in Shilpa AO, et al., 2006 [38]. The experimental group
(SMSP or IPGR) was generated after cross-fostering between
intrauterine semi-nutrient (50% food intake, e11–e21 gestation)
restricted pups (SP) and semi-nutrient (50% food intake, d1–d21)
restricted mothers (SM). The control animals were made by the
same way using control (ad-libitum food 22 g/day, e11–e21) pups
(CP) and control mothers (CM). 450 days of postnatal adult male
rats were used for this study.
RNA isolation, micro-RNA enrichment, RNA quality
Total RNA was isolated from rat skeletal muscles using
Invitrogen Trizol reagent. The muscle tissues were cut into pieces
and frozen in liquid nitrogen, then ground into powder in mortar
and pestles and stored at 280uC. For enriched fraction of micro-
RNA isolation quantitatively from tissues and cells, the mirVana
miRNA isolation kit of Ambion was used. RNA quality was
measured by mass spectrometry and agarose-gel electrophoresis by
examination of the band integrity of ribosomal RNA(s).
Microarray analysis
The Exiqon (Vedbaek, Denmark) miRCURY LNA microRNA
arrays and service to process the samples were used. A mixture of
equal amounts of total RNA from the sk. muscle of control
(CMCP) and the experimental (SMSP/IPGR) were used as the
reference pool. A total of 2 mg RNA from each sample was then
labeled with the Hy5
TM fluorescent label and the reference pool
labeled with Hy3
TM using the miRCURY
TM LNA Array labeling
kit (Exiqon). The labeled samples and reference pool were then
mixed pair-wise and hybridized to the miRCURY
TM LNA array
containing capture probes targeting all rat miRNAs listed in the
miRBASE version 8.1 (Exiqon). In addition, the array contained
capture probes for another 10 spike-in control microRNAs
(Exiqon), which can be used for further calibration or control of
the profiling experiment. After hybridization, the slides were
scanned, quantified signals and normalized by Exiqon using the
global Lowess (Locally Weighted Scatterplot Smoothing) regres-
sion algorithm.
RT-PCR analysis
The mirVana miRNA isolation kit along with the mirVana qRT-
PCR primer sets (including reverse primers for RT reactions) of
Ambion were used for semi-quantitative micro-RNA analysis. The
first step for this protocol was RT reactions of microRNA enriched
RNA molecules followed by the synthesis of amplified PCR
reactions instead of qPCR analysis. The decision was made to
follow the regular controlled PCR reactions with optimum cycles
determined in separate reaction sets using the specific RT primer
of Ambion and the micro-RNA specific primers designed by the
same company.
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The total RNA sample (10 mg) was run on a denaturing 12%
polyacrylamide gel containing 8 M urea and the fractionated RNA
samples were then transferred to Nytran-N (Amersham Biosci-
ence) membranes by capillary method and fixed by UV cross-
linking according to the manufacturer’s instructions. For radio-
labeling of the miRCURY
TM probe, 20 pmole probe was used for
the end-labeling reaction combined with gamma-32P-ATP and
T4 polynucleoitde kinase according to standard protocol. The
membrane was pre-hybridized in small RNA hybridization buffer.
(50% formamide, 0.5% SDS, 56SSC, 56Denhardt’s solution, and
20 mg/ml sheared denatured salmon sperm DNA). The mem-
brane was hybridized in the same solution at 45uC overnight after
addition of the labeled miRCURY
TM probe (Exiqon) boiled for
one minute. The membranes were washed at low stringency in
26SSC, 0.1% SDS at room temperature twice for five minutes
followed by high stringency washes @ 0.1 SSC, 0.1% SDS at 65uC
twice for five minutes. The membranes were then exposed in X-
ray film and incubated for 48 hours followed by visualization
through autoradiography.
Cloning, transfection and luciferase assay
The vector pMIR-REPORT (Luciferase-based) is designed for
the cloning and testing of putative miRNA binding sites (Ambion
Inc.). This plasmid can be transfected into mammalian cells to
evaluate either endogenous miRNA expression, or to evaluate up-
or down-regulation resulting from the transfection of Pre-miR
TM
miRNA and Anti-miR
TM miRNA molecules. The 39UTR of the
SMAD4 gene was cloned into the Hind III and SpeI sites of
reporter MCS. The luciferase expression is driven by the CMV
promoter in vivo. The addition of the target gene 39UTR in the
downstream luciferase gene (as the 39UTR) alters its expression
pattern in RNA translational levels. Upon transfection in the cell
culture system along with or without Pre-miRs and Anti-miRs for
48–60 hrs, the luciferase activity and the protein concentration
were measured in a Luminometer using Promega luciferase assay
reagent and Biorad reagent assay, respectively, according to the
manufacturer’s protocols. The negative control Pre-miR, Negative
Control #1, miRNA of Ambion is a non-targeting sequence that
bears no homology to the sequences of human, mouse, or rat
transcripts. 25 nM final concentrations of both Precursors mimic
micro-RNA and anti-miR miRNA inhibitors were used in this
study. Transfection of muscle cells with micro-RNA were done
using either siPORT NeoFX transfection reagent from Ambion,
with siRNA done using Lipofectamine RNAiMax, and with
plasmid DNA done using Lipofectamine 2000 from Invitrogen.
Cell culture analysis
Mammalian skeletal muscle cell-lines (bought from ATCC) of
rat origin L6 myoblasts and H9c2 cardiomyocytes (embryonic
heart tissue, myoblast morphology) were used in this study. L6
myoblast cells were maintained according to the ATCC protocol
using DMEM with 4 mM L-glutamine adjusted to 0.15%
bicarbonate and 0.45% glucose in addition to 10% FBS. The
cells were maintained in low confluency with 3 passages every
week with change of medium every 2–3 days unless stated
otherwise for any particular experiment. All the experiments
involving the L6 cell-line were performed within 10 passages from
initial thawing. Once the cells were received from ATCC, cells
were cultured for 2–3 passages, then aliquoted and frozen in liquid
nitrogen. For myocyte-myotube formation of the skeletal muscle
cells, serum deprivation for (mostly 2%) 8–12 hrs was manifested.
For transfection experiments, cells were seeded 2 days early with
30–40% confluence. By the end of 48 hrs, the plates were
populated with 70% confluence.
Glucose transport assay
The basic protocol for glucose transport assay in rat L6 cell
culture system is taken from Klip et al., 1984. L6 cells were grown
in DMEM with regular 10% FCS and 4.5 mM glucose until
reaching 80% confluence followed by changing medium with a-
MEM with 2% FCS to saturation in 12 well plates. The
differentiation into myocyte-myotube formation was tracked by
looking at the multinucleated cells under a microscope. Cells were
washed by 26 a-MEM/0.1% BSA (pH 7.4) followed by serum-
free step-down for 6 hours in the same medium in a 5% CO2
incubator. Cells were washed in 26KRH/0.1% BSA followed by
glucose-free step down with or w/o insulin for 45 minutes (50 nM)
in 0.45 ml KRH/0.1% BSA at 37uC. Plates were washed three
times quickly with reaction buffer (150 mM NaCl, 5 mM KCl,
1.2 mM MgSO4, 1.2 mM CaCl2, 2.5 mM NaH2PO4,1 0m M
Hepes pH 7.4, 0.1% BSA). 0.5 ml of this buffer was added to each
well and the transport reaction was started with the addition of
radioactive (0.5 mCi
3H-OMe-Glucose and/or
14C-2-deoxy glu-
cose) substrate of final concentration of 0.15 mM. Cytochalasin B
(Sigma), 10 mM, and insulin (Sigma, bovine pancreas), 50 nM,
were also used during the transport reaction if permitted for the
experiments. The transport reaction was continued for 6 minutes
(linear phase under the conditions, data not shown) terminated by
vacuum suctioning off the reaction solutions immediately followed
by cold wash with PBS, three times. The cells were dissolved in 0.1
N NaOH, 0.5 ml followed by neutralization with 1 N HCl. A
fraction of the cell extract was used to measure both radioactivity
in the scintillation counter and protein concentration by Bradford
reagent.
Tissue fractionation for Western Blot analysis
The compartmental cell fractionation kit of Chemicon Inc./
Millipore was used to isolate the proteins from rat skeletal muscles
into cytosolic, nuclear, membrane and cytoskeletal fractions. The
protocol was standardized by SDS-PAGE and Western Blot
analysis using various protein markers for compartmental proteins.
GAPDH, Histone, EGFR and Vimentin were used for cytosolic,
nuclear, membrane and cytoskeletal proteins. The SKM samples
were pulverized under liquid nitrogen and stored at 280uC
followed by power homogenization for four times. Equal amount
of proteins were loaded in SDS-PAGE from control (CMCP) and
experimental (SMSP) samples, then run and transferred onto
PDVF (Invitrogen Inc.) membranes for Western Blot analysis.
Primary antibodies described in the antibody section were used for
the blots according to the manufacturer’s protocol using either 5%
milk, 3% BSA, or just PBS-Tween depending on the quality and
nature of the antibodies. Anti-rabbit, anti-mouse or anti-goat
horse-radish peroxidase (HRP) tagged secondary antibodies were
used against the appropriate primary antibodies for luminol-based
ECL/ECL-Plus detection.
Statistical analysis
Student’s T-test was always performed between two sets of data,
for the control versus each experimental micro-RNA treated. The
intention was to see the significance between these two groups,
rather than among the groups performed in some experiments.
The criteria for T-test significance was based on the two-tailed
distribution and for paired or equal variance type.
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Glut4 mRNA expression level remains unaltered in male
IPGR rat SKM
The predominant isoform of glucose transporter 4 is essential in
functioning as a carrier of glucose molecules across the cell
membrane in vivo, specifically in skeletal muscles and adipose
tissues of mammalian origin [39,40]. We have found the
expression of this pivotal membrane-spanning protein is dimin-
ished in female rat SKM under the experimental calorie-restrictive
starved conditions both in vivo and in vitro cell-culture conditions
[32]. Major transcriptional networks in Glut4 expression have
been studied in this system and a number of epigenetic factors
were found to be responsible for this diminution of Glut4
expression level. Having found the significance for this restricted
glucose transport activity in female rat sk. muscles in the
development of insulin resistance in future progeny of the starved
pregnant mother, I became interested to find out the trend of
Glut4 expression in the male rat counterpart for possible detailed
study from the epigenetic point of view. No changes were
detectable in Glut4 mRNA expression in the male SMSP group of
the study compared to CMCP. In Fig. 1, the northern Blot (a, b)
and real-time RT-PCR (c, d) has been performed using total RNA
of the SKM samples (n=6). The relative intensity of Glut4 per
unit of b-Actin and rRNA species is expressed for two groups and
no statistically significant result was found between the groups
(p=0.18). This observation was verified by real-time PCR using
the same total RNA and led to the same conclusion. This
contrasting result between the gender samples in the IPGR model
left several questions unanswered regarding the regulation of gene
expressions in this regard. The major question that arose was how
the male SKM counterpart was resistant in Glut4 expression status
and what phenotypic differences were possible under the
experimental conditions compared to female rats. To investigate
this gender-specific difference in gene expression, the focus was
placed on the translational control of mRNA that might be
important in regulating GLUT4 mRNA translation given the
importance on the regulation of initiation of translation after stress
[41]. As microRNA controls the translational initiation by partial
binding to the 39UTR of many mRNAs, and the aberration of
microRNA expression has been considered to be significant in
regulating the epigenetic status of the muscles tissues [42–45], a
bioinformatics analysis was made regarding the possible putative
binding sites for muscle-specific or any putative microRNA that
may regulate the GLUT4 expression in possible alternative
mechanistic routes. Unfortunately, there is no microRNA known
or found in the bioinformatics searches (e.g., Sloan-Kettering
microRNA site and mIRANDA) that could potentially bind the
Glut4 mRNA directly on its 39UTR sequences at that time of
investigation. The alternative possibility of affecting Glut4
expression and thus the glucose transport activity in SKM is
through an indirect mechanistic process of altering the signaling
associated with GLUT4 translocation in the membrane from the
cytosolic reservoirs [46]. Any targeting by microRNAs would
reveal and possibly explain the differential status of expression
patterns in a gender specific manner. This, thus, led to the
investigation of global microRNA expression patterns in the
experimental SMSP samples compared to the control male rat
muscles. This would reveal the miRNA-specific targeting of
muscle glucose transport activity, if there is any.
Identifications of microRNA(s) that are either over or
underexpressed in the experimental SMSP skeletal
muscle samples
LNA-based miRCURY (Vol. 8.1) microRNA array technology
by Exiqon Inc. was utilized to find the group of microRNAs that
might be over-expressed in the SMSP group relative to the control
CMCP tissues. This locked-nucleic acid based microarray
technology offers the most sensitive and specific hybridization
with the sample RNA preparations using the Tm normalized
capture probes and by spike-in control microRNA probes
incorporated within the reaction mixtures. The CMCP and
SMSP total RNA from the equimolar mixtures of n=6 RNA
samples prepared from Ambion’s miR-Vana isolation kit was
verified for their integrity by mass-spectrometry (figure not shown)
and then labeled by Hy3 and Hy5 dye respectively. The
experiment was performed in triplicate and regression analysis
was done for reproducibility (R
2=0.99). Ten different spike-in
controls were used for assessment of the data quality. Spot
morphologies were obtained and intensities were scanned using
the Exiqon software program. The log2 ratio of Hy3 to Hy5 was
plotted for all 61 microRNAs that bind the template harboring rat
261 microRNAs in the hybridization process (Fig. 2). The over-
expression of miR-29a, 23b, 23a, 1 and let7a in SMSP (1–6):Hy5
and miR-129*, 103, 483, 107 and 326 in CMCP (1–6):Hy3 have
been observed. Only two-fold or nearly two-fold over-expression
has been observed in some cases, mostly in miR-29a for SMSP
and miR-129* for CMCP. An endpoint RT-PCR miRNA
detection kit using Ambion miRVana qPCR was used. Figure 3
shows the 22 cycles (mid log of exponential phase, data not shown)
of end products in RT-PCR reactions for let7a, miR-23a, miR-
23b, miR-1 along with GAPDH as an internal control.
Distinctively, miR-1, let7a and miR-29a expressions were much
higher in SMSP experimental samples (n=6) than in control
CMCP rat muscles. Density scanning of the bands revealed a
statistically significant difference (p,0.05) of ,1.5–2.0 fold
increase of the microRNA expressions as found in the microarray
analysis (Fig. 3. I). MiR-23a seemed to have higher expression in
experimental tissues but not statistically significant levels
(p=0.065), whereas miR-23b expression was not altered like in
internal control GAPDH (p=0.13; Fig. 3. II). This small
microRNA miR-29b is serving also as an internal control because
this regulatory molecule turned out to be not significant. In order
to see the effective mature microRNA molecules, denaturing
polyacrylamide gel electrophoresis was conducted followed by
Northern Blotting using
32P-labeled miR-23a, miR-129*, miR-1
and let7a specific LNA Probes. MiR-129* is under-expressed in
the experimental samples compared to the control (Fig. 4, panel I).
This was included in the gel electrophoresis in order to verify the
authenticity of the assay. Mature miR-23a was found to be over-
expressed as revealed in the LNA-based microarray (Fig. 4, panel
1). Northern Blotting also revealed the precursor molecules (70–
100 nucleotides) for individual microRNAs. Surprisingly, in miR-1
Northern Blot, almost no detectable mature miR-1 was found in
control CMCP compare to SMSP, whereas the level of precursor
forms remained unaltered (Fig. 4, panel II). This may suggest an
unidentified mechanism becomes activated in order to generate
the mature miR-1 molecules in the experimental starved adult rat
male SKM. Fig. 4 Panel III shows the relative intensities of these
mature microRNAs with approximately 3–4 fold differences
between the experimental and control groups.
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SKM while the Insulin-signaling pathway becomes
positively regulated: Identification of few possible
microRNA targets that may play important role in
glucose transport in SKM
Although LNA based-miRCURY microarray produced results
reproducible in further analyzing differences in in vitro confirma-
tion of the over-expression of let7a, miR1, miR-29a and miR-23a
in SMSP samples, the approach taken here was focused on the
identification of target protein genes for the respective microRNAs
that affect the glucose transport pathways in SKM. As a first step
of this process, bioinformatics tools have been explored;
specifically the Sloan-Kettering site for microRNA target identi-
fication software was available in open access Internet search.
First, we have identified several putative target mRNA 39UTR
sites matching a profound homology in terms of physicochemical
stabilities with the microRNA species over-expressed in our
system. I focused on those protein factors that were significantly
down-regulated as possible direct targets of respective micro-
RNA(s) that regulate or putative regulator of glucose transport
process. This approach may significantly reduce the time required
for global experimental searches, such as proteomics. The sk.
muscle individual samples from six different rats were homoge-
nized and fractionated into four different major fractions in order
to see the compartmental localizations of the putative protein
factors and their relative levels in control (CMCP) vs. experimental
(SMSP) samples. In order to do this experiment, Chemicon
International’s proven standardized, reproducible, sequential
compartmental protein isolation kit was used for dissecting semi-
quantitative separation of individual proteins of interest [47,48].
The cross-contamination of the four fractions was checked (Fig. 5)
for the standard proteins. The bottom panel of Fig. 5 shows a little
contamination of cytoplasmic protein GAPDH in the nuclear
fraction which is probably a part of the perinuclear membrane.
EGFR, a membrane-localized protein mostly came into the
membrane fraction except little as nuclear fraction, again may be,
as a part of perinuclear membrane. Nuclear protein Nucleolin is
mostly found in nucleus and some cytoplasm. Nucleolin has
translation function in cytoplasm too. We need to remember that
it’s not ‘all or none’ in terms of localization and function and
equilibrium. The cytoskeletal fraction was not tested for its cross-
contamination. SDS-gel electrophoresis followed by Western
Blotting technique was performed using the extracted cellular
proteins sequentially isolated from cytosolic, nuclear, membrane
and cytoskeletal fractions. Based on previous knowledge of sub-
cellular protein localization, the semi-quantitative estimation of
the level of respective proteins by Image J analysis of the band
intensities was compared between the two groups. The pattern of
expression of protein signaling factors for GLUT4 translocation to
the membrane in response to insulin binding to its receptors would
tell us the status of the glucose transport activity in the starved
(SMSP) muscle samples. GLUT4 expression was found to be
increased in the membrane fraction by 33.3% (p,0.05) (Fig. 5) in
contrast to the female SKM where there was a similar decrease of
GLUT4 expression, both in mRNA and Protein levels [32]. No
differences were observed in the total amount of GLUT4 levels
(Fig. 5) between the two extreme groups, reinforcing the idea that
no transcriptional regulation may be associated with the Glut4
expression in male SKM (Fig. 5). As there was no change of
mRNA level between these two groups of male-specific muscle
tissues (Fig. 1), it is suggested that the chronic starved male sk.
muscle in IPGR rat model behaves differently than that of female
counterpart where the transcriptional repression event is demon-
strated. Interestingly, Insulin-like Growth Factor-1 receptor
(IGF1-R) is also over-expressed in the experimental membrane
fraction by 133% considering CMCP as 100%, along with the
GLUT4 receptor, probably because SMSP starved cells need
more IGF signaling in male sk. muscle under this circumstance for
facilitating glucose transport inside the cells. Insulin-dependent
and IGF1-dependent glucose transports are two parallel intercon-
necting mechanisms active in many cell-lines and subcellular
tissues [49–51]. Importantly, the expression levels of GLUT1 and
GLUT3 isoforms of glucose transporter did not change in the
membrane fraction at all, implying that GLUT4 is recognized as a
Figure 1. Glut4 mRNA expression level does not alter with the IPGR semi-calorie food restricted male rat skeletal muscles. A.
Representative Northern blot analysis using total RNA isolated from six male rat SKM samples (450 days-IPGR) of both control (CMCP) and food
restricted animals (SMSP). GLUT4 and b-Actin specific probes were used in hybridization. Ethidium bromide stained 28S and 18S ribosomal RNA is
used as loading control. b-Actin is used as internal control. B. Intensity of the band was quantitated and expressed as percentages. C. Real-time PCR
has been performed using the same RNA samples (1–6) of CMCP and SMSP male rat SKM using GLUT4 specific TaqMan probe and primers using
GAPDH, Glyceraldehyde-3-phosphate dehydrogenase, as internal control and D. Average of six samples.
doi:10.1371/journal.pone.0034596.g001
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in cultured myocytes-myotubes in both insulin and IGF1-
dependent glucose transport activity. As a control, membrane-
dwelling epidermal growth factor receptor (EGFR) expression was
tracked from two groups as it is known that this receptor functions
as EGF-induced membrane glucose translocation in transgenic
3T3-L1 adipocytes [52], and this protein appears to be a bonafied
membrane-spanning internal control protein. There was no
EGFR expression difference between the groups. Glucose-6-
phosphate dehydrogenase (G6PD) is the rate-limiting enzyme in
the pentose phosphate pathway. This rate-limiting enzyme is also
known to be induced by insulin-dependent activation of
phosphatidylinositol 3-kinase (PI-3 Kinase) [53]. The observation
that G6PD is highly up-regulated in SMSP muscles (,180%)
suggests a hypothesis that a similar mechanism may exist in this
regard (Fig. 6). So, it is expected that GLUT4-mediated glucose
transport activity may be switched on through either insulin or
IGF1 mediated activation of PI-3K signaling in these SKM
samples. Evidence has firmly established the involvement of PKC-
f in GLUT4 translocation in a variety of adipose and muscle cell
lines. The PI3K downstream activator PIP3 is a suitable candidate
for PKC-f activation [54]. This unusual protein kinase C has been
shown to bind with Rac1 GTPase (Cdc42) and mediates ‘Actin-
remodeling’ in L6 myocytes, leading to insulin-induced glucose
transport [55]. In male rat IPGR muscles, PKC-f phosphorylation
(Thr-410) is activated by 58.8% compared to the total forms of
PKC-f which remain unaltered (Fig. 6). A similar activation of the
PKC-f (Thr410 P) was documented in the female counterpart
SMSP samples (IPGR) in absence of ex-vivo addition of insulin
[38]. In this paper, the authors described the aberration of insulin
signaling in the food-restricted model of IUGR female rat. In the
male counterpart of IPGR sk. muscle, Cdc42 GTPase and b-Actin
expression patterns, however, were not changed significantly
(Fig. 6) between the groups, suggesting that remodeling may only
exist under the experimental conditions and further experiments
are required to draw a valid conclusion. ARF1 GTPase is up-
regulated by 28.8% in SMSP SKM, suggesting its possible
involvement in structural muscle rearrangement for in vivo muscle
development in IPGR offspring (Fig. 6). Upstream AKT3/PKB
expression is also increased by 30.7% in the SMSP groups, but
Figure 2. Over-expression of some microRNAs is observed in IPGR SKM samples over the control animals. Differential expression
profile of sixty micro-RNAs that bind to the Chips in LNA-based microarray analysis (Exiqon miRNA-vol 8.1) of male rat SKM micro-RNA enriched
samples isolated from CMCP (CC1-6) and SMSP (SS1-6) animals. CC1-6 samples are labeled with Hy3 and SS1-6 by Hy5 dyes. Log2ratio of Hy3 by Hy5
is plotted against every bound microRNAs. Sample size was N=3 and 10 different spike-in controls have been used for the experiment as internal
control.
doi:10.1371/journal.pone.0034596.g002
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Vesicle-Associated Membrane Protein 2 (Vamp2) has been
implicated in the stimulation of glucose transport activity in
conjunction with PKC-f. Activation of PKC-f induces serine
phosphorylation of Vamp2 in the GLUT4 compartment upon
insulin treatment in primary cultures of rat skeletal muscles [56]. A
ninety-two percent increase of Vamp2 (p,0.05) was found in the
cytoskeletal fraction of the restricted group compared to the
control muscle, but no change in total Vamp2 protein levels has
been observed in the membrane fraction (Fig. 5, 7). Serine
phosphorylation of Vamp2 was also increased in the SMSP group
as was the total protein in the cytoskeletal fraction of the cell
extracts (data not shown). Another interesting observation was the
drastic over-expression of a mesenchymal protein marker,
Vimentin, in the cytoskeletal fractions of the experimental groups
(abruptly increased, p,0.1, Fig. 7) which was initially planned to
be included as CS resident marker. This marker protein is usually
found in regenerating skeletal muscles in the early myoblast phase
of proliferation in the fetus SKM and then found in decreasing
levels while in the late stage of differentiation forming myocyte-
myotubes particularly in sarcomere development [57]. This is
perhaps highly suggestive that the SMSP group of rat SKM under
the chronic starved condition creates a more regenerative and
mobile Vimentin-expressingmuscle cells for repair and develop-
ment of new muscle cells from stem cells. Tropomyosin C level
was much less in this food-restricted muscle group (21.5% decrease
in cytosolic fraction and p=0.01; Fig. 5) compare to myosin level
(remains unaltered, data not shown) suggesting a possible
functional significance thriving for regular muscle contractions,
probably by exposing more G-Actins for interactions with Myosin
motor heads [58]. Most of the protein factors that I discussed and
presented here are based on the computer simulation in
microRNA binding sites of interest in those putative genes
39UTR. But, if there is a direct binding of the microRNA(s) that
were over-expressed in SMSP sk. muscle with some of the putative
targets, we should expect the decrease in protein expression level
in the semi-calorie food restriction group. Nuclear protein
Nucleolin binds to target 39UTR for mRNA stability under stress
conditions e.g., anti-apoptotic factors [59]. Ncl mRNA have a
miR-1 binding site (Alignment score 168.2 and energy for binding
mRNA target sequence, 215.17; Fig. 8). The expression of this
protein is decreased significantly in SMSP rat muscles by 25%
(p,0.05) suggesting that it may play a role in destabilization of
protein factors in stressed muscles. Another regulatory protein
dnaJ-B1, an isoform of HSP40 chaperone, has the binding site for
miR-29a of alignment score 147 and stability 219.55 (Fig. 8). At
present, a function for these two proteins associated with muscle
development and growth, including glucose transport function, is
not characterized. DnaJ-B1 level is found to be significantly
(p,0.5) less (15.7% decrease) in the experimental animals
compared to the controls (Fig. 6). Gene expression profiling of
human sk. muscle suggested dnaJ-B2 is likely involved in muscle
growth, remodeling and in stress regulation [60]. More direct
questions to be asked in finding out the role of these proteins in the
functional aspects of sk. muscle metabolisms and the associated
regulations in glucose transport activity. More significantly,
another extremely important regulatory protein factor, SMAD4,
which is pivotal in TGF-b signaling of muscle growth and
differentiation, was found. Central co-SMAD, Mothers Against
Decapentaplegic Homolog 4, bears putative binding sites for three
different microRNAs miR-1, miR-29a and let7a (Fig. 8). It is
tempting to speculate that this particular regulatory protein may
play an important role in glucose metabolism either directly or
indirectly if proven to be real target. TGF-b-SMAD pathway
controls the sk. muscle growth and differentiation under various
circumstances and proved to be essential for muscle function both
in embryonic and adult mammalian tissues. Muscle-specific
conditional inactivation of TGF-b super-family gene, myostatin,
modulates the sk. muscle mass [61] and similar gene, GDF8 is
known as inhibitory to the muscle growth in mice [62]. Schabort et
al [63] demonstrated the role of TGF-b in promoting proliferation
and delay in differentiation of mice-origin C2C12 myoblast cells.
It is not surprising that SMAD4, a central regulator of TGF-b
function in sk. muscle glucose metabolism.
Transient transfections of precursor micro-RNA(s) and
anti-miR(s) in rat L6 skeletal muscle cell-line demonstrate
a stimulatory role for miR-29a in glucose transport
activity in general whereas miR-23a for insulin-
dependent function in the same
I asked the question directly in an established rat cell-line
whether miR-1, miR-23a or miR-29a play a role in regulating
glucose transport activity (GTA) in vitro, delineating the possible
Figure 3. Semi-quantitative RT-PCR analysis of microRNAs in
male SKM samples. I. The total RNA (1 mg) has been used to make
cDNA using Ambion mirVana isolation kit. Equal amount of cDNA has
been used in separate microRNA-specific PCR reactions. CMCP (1-6) and
SMSP (1-6) correspond to six samples of control and starved SKM. II.
Image J analyses of the intensities of all bands were plotted as graphs
for each microRNAs. T-test was done as a measure of statistical analysis.
GAPDH was used as an internal control.
doi:10.1371/journal.pone.0034596.g003
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SMSP muscle tissues. Although let7a microRNA is found to be a
highly prominent potential candidate for this GTA activity in our
system, this regulatory RNA molecule proved to be complicated in
its function of regulating GTA (data not shown) and thus I have
decided to omit let7a data in this publication until further
investigation. Ambion Inc. has developed a transfection-based
functional assay using synthetic precursor small dsRNA molecules
(Pre-miR) that mimic the dose-dependent up-regulation of mature
microRNA suitable for gain-of function studies using C
14-2-
deoxyglucose and the non-metabolized glucose analog 3-O-
(methyl-
3H)-D-glucose either by dual labeling or individually in
presence or absence of cytochalasin B, an inhibitor of glucose
transporter-mediated glucose uptake. Pre-miR transfection exper-
iments were performed in L6 myocyte-myotube cells according to
the protocol described in Method. Radioactive-glucose uptake
inside the cells was compared among Mock vs. Pre-miR
transfected cells per OD protein minus cytochalasinB treated
(10 mM) transporters-independent transport if added. Fig. 9A
shows a picture of total GTA, independent of insulin and
cytochalasin B treatment. All of the Pre-miR-transfected cells
demonstrate the up-regulation of glucose transport activity both in
normal and non-metabolized radioactive glucose substrates added
together in the master-mix. MiR-29a significantly up-regulates
GTA (p,0.01), whereas both miR-1 and miR-23 tend to increase
the transport activity (for miR-1 p=0.06 and 0.08; for miR-23a
p=0.08 and no difference; Fig. 9A, B) compare to the mock
treatment. These results suggested an inhibitory function of some
unknown target protein(s) of these microRNA(s) involved in
regulating glucose transport uptake in general. The specificity of
the glucose transporter-mediated glucose transport process was
examined with cells transfected with the same Pre-miRNA(s)
under the same condition except that the 50 nM insulin for
30 minutes was added in the culture prior to and during the
transport assay. Fig. 9B (I) clearly shows the reduced transport in
the presence of cytochalasin B (subtracted the values obtained with
cytochalasin B) and recapitulates the results of the previous
experiment just before the addition of insulin. After the addition of
Insulin, muscle cells demonstrate more than a two-fold induction
of total glucose transport, approximately same as other people
published elsewhere in L6 cell-line. In this case, exogenous
addition of miR-23a resulted in a more than six-fold increase in
GTA in response to insulin in comparison to only less than 3-fold
stimulation due to insulin addition (Fig. 9B, III). The major active
Figure 4. Analyses of mature microRNAs of interest found in both micro-array and RT-PCR analysis. Denaturing Urea-Acrylamide gel
electrophoresis of total RNA (10 mg) have been run and subjected to Northern Blot analysis using P
32-labelled LNA-based microRNA probes (Exiqon)
either as mixed samples of 6 SKM RNA (I) or separately for 6 samples for miR-1 (II). The single arrow stands for the mature microRNA of appropriate
size and the double arrow signifies the precursor forms, 60–100 bases. SMSP is the experimental against CMCP as control animal samples. III. Relative
intensities of the bands in I and II.
doi:10.1371/journal.pone.0034596.g004
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dependent, and is probably responsible for this change of glucose
transport activity as also revealed in immunoblot analysis of the
skeletal muscle tissues by GLUT4, 1 and 3 antibodies in the
membrane fraction (Fig. 5). In vitro starved L6 muscle cells may
have positively induced the similar microRNA as was in food-
restricted animal tissues that will need further experimentation. As
the control mock-treated cells had gone through the same
treatment and protocol, it is safe to conclude the result in the
experimental group. This experiment using the gain of function of
mature microRNA(s) incorporated inside the cells, for the first
time, reveal two microRNA(s) that up-regulate the insulin-
dependent and independent glucose transport processes in starved
muscle cells that may explain the over-expression of GLUT4,
IGF1-R proteins and other insulin-signaling proteins (e.g., PKC-f,
Vamp2) in SMSP SKM samples (Fig. 5, 6, 7). Next, it was
determined whether I would obtain results in line with the over-
expression studies using anti-miR precursor molecules. I knocked
out the cellular microRNAs by anti-miR inhibitors developed by
Ambion Inc. The ‘ready-to-use’ chemically modified single-
stranded RNA molecules bind with target endogenous miRNA
specifically depleting their level significantly and has been tested in
house successfully for their effectiveness (Ambion Inc.). So,
depleting individual miR molecules endogenously by these
siRNA-like inhibitors may answer questions about the function-
ality of these regulatory molecules. While checking the glucose
transport activity in L6 myocytes transfected with the anti-miR
inhibitors, almost no change was observed in glucose transport
activity in the absence of insulin except there was a trend of
diminished transport activity for miR-23a of no statistical
significance (Fig. 10). But the functional significance of miR-29a,
in the absence of insulin, could not be verified under the condition.
This suggested that excess miR-29a molecules might have targeted
multiple targets, giving rise to functional stimulation of GTA
whereas; the endogenous depletion caused unchanged GTA in
absence of insulin. However, in the presence of insulin, all the miR
Figure 5. Cellular fractionation of possible target proteins based on microRNA bioinformatics analysis and the insulin-signaling
proteins for glucose transport: Membrane fraction. The biochemical fractionations of the membrane proteins were made using Chemicon/
Millipore’s compartmental sub-cellular analysis technology. Cytosolic, membrane, nuclear and cytoskeleton fractions have been made from SKM
tissues from both control (CMCP) and experimental (SMSP) male animals. SDS-PAGE followed by Western Blot analysis was made using 50 mg of total
protein from every fractions based on Bradford assay. The localization of GLUT4 and IGFR in IPGR male SKM is significantly increased in membrane
fractions when the total GLUT4 protein level remains unaltered in male SKM. GLUT1, 3 and 4 are Slc2 group of glucose transport proteins, IGFR is
Insulin Growth Factor Receptor protein, EGFR is used as internal control for membrane localized protein. Vamp2 and Vimentin are two essential
regulatory protein markers for insulin signaling and cell differentiation. b-Actin was used as internal control for total protein. The bottom panel
represents the verification data for the cell fractionation. GAPDH, Nucleolin and EGFR were used for cytosolic (C), nuclear (N) and membrane (M)
localized proteins. T represents total protein.
doi:10.1371/journal.pone.0034596.g005
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miR-23a that brought about a statistically significant decrease of
glucose transport (Fig. 10; p=0.01). Anti-miR-29a also showed a
significant decrease in GTA (p,0.05), indicating a role for the
regulation in glucose transport process in SKM. This was in line
with the over-expression experiment in presence of the insulin
Figure 6. Cellular fractionation of possible target proteins: Cytosolic fraction. Insulin signaling marker is up-regulated along with the
metabolic marker glucose-6-phospahe dehydrogenase and ARF1 GTPase, whereas SKM marker Tropomyocin C is down-regulated along with two
essential signaling candidates SMAD4 and DnaJ-B1.
doi:10.1371/journal.pone.0034596.g006
Figure 7. Cellular fractionation of possible target proteins: Cytoskeletal fraction. Insulin-signaling protein VAMP2 is upregulated along
with the regulatory protein Vimentin, whereas SMAD4 TGF-b co-SMAD is down-regulated. NSP represents non-specific protein serving as internal
control.
doi:10.1371/journal.pone.0034596.g007
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compared to the negative control treated cells (p,0.01). Given the
specificity of the LNA-based anti-miR(s), it is not conceivable to
imagine that anti-miR-29a would react with other related miR(s)
to make the GTA unchanged under the condition of insulin-
independent manner. So, considering the gain of function
experiment using Pre-miR-29a, it is very likely that the microRNA
concentration is critical in targeting multiple factors to affect
insulin-independent glucose transport activity. In adipocyte cell-
line 3T3-L1, it has been shown by Aibin H et al. [64] that miR-
29a/b/c over-expressions through Adenovirus-mediated delivery
were accompanied by the inhibition of insulin-dependent glucose
transport activity. In our system, the exogenous addition of micro-
RNA 29a in rat muscle cells did not alter the effective insulin-
dependent total glucose transport as compared to the control mock
transfection with or without insulin (Fig. 9B. III). The microRNA
miR-1 did not show any effect in vitro by changing the GTA either
in presence or absence of insulin. Again, presumably, the level of
microRNA and its expression in cells seems to be very important
in selecting single or multiple targets which are responsible for
GTA inside the cells. Further studies are needed using the
controlled expression system of microRNAs in order to understand
the intricacy of these small RNA elements for regulating sk. muscle
glucose transport processes.
The protein factors SMAD4, DnaJ-B1, and nucleolin, are
possible targets of miR-29a, miR-23a and miR-1
Based on the expression patterns of the various protein factors
that have putative target sites in their 39UTR against the
microRNA(s) that were over-expressed in the male SKM of the
SMSP group of IPGR rat starvation model, SMAD4, DnaJ-B1
and nucleolin are the prominent ones that may affect the glucose
transport activity in skeletal muscles. All of these plausible target
protein levels were gone down significantly (p,0.05) in the sk.
muscle SMSP samples (Fig. 6, 11). Cytosolic and cytoskeletal
SMAD4 levels had gone down drastically in SMSP (by ,50%) of
P values (T-test) 0.004 and 0.015 respectively (Fig. 6, 7), but the
nuclear level of SMAD4 remained almost unaltered (14.3%
decrease without significance, Fig. 11). SMAD4 is a critical TGF-b
pathway co-SMAD that binds to other SMADs (e.g., SMAD3 and
SMAD1) for nuclear translocations for transcriptional activation in
this pathway. The 39UTR of SMAD4 harbor the recognition sites
for miR-1, miR-29a and let-7a according to the bioinformatics
analysis (Sloan-Kettering Institute micro-RNA site, http://www.
microrna.org/ microrna, Fig. 8). According to the alignment
scores and energy levels, let7a.miR-29a.miR-1 towards
SMAD4 target sites (Fig. 8). Unfortunately, let-7a interaction with
SMAD4 was intentionally not studied in vitro because of the
complex nature of this microRNA towards the glucose transport
functional assay in L6 skeletal muscle cells (data not shown). DnaJ
B1 and nucleolin 39UTR recognizes miR-29a and miR-1
Figure 8. SMAD4, is one of the targets for miR-29a and/or miR-23a: Bioinformatics analysis. miR-1, miR-29a and miR-23a for SMAD4,
DnaJ-B1 and nucleolin 39UTRs. MIRANDA and Sloan-Kettering MicroRNA target analysis site were used for this analysis. Alignment score, PhastCons
score and Energy values were cited for all the interactions.
doi:10.1371/journal.pone.0034596.g008
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miRANDA alignment score and energy of stabilizations. These
protein levels (DnaJ B1 & nucleolin) were found to be down-
regulated in the IPGR experimental animals compare to the
controls (15.7% and 15% decrease respectively with statistical
significance P=0.04; Fig. 6, 11). Nuclear proteins HDAC4,
MEF2C and HAND2 transcription factors were implicated for
GLUT4 metabolism in sk. muscle [32,65,66] and found to be
targeted by miR-1 and miR-23a in bioinformatics analysis.
Interestingly, HDAC4 and MEF2C were also down-regulated by
20 and 19% respectively with p values 0.05, whereas HAND2
came out to be unaltered (Fig. 11). I did not pursue HDAC4 and
MEF2C because of no GLUT4 transcriptional differences exist
between the groups.
Out of three promising proteins factors, SMAD4 has the best
chance to be a good candidate because of the severity of the effects
observed in animal experiment. In order to check out the target
protein’s candidacy as a possible target of these microRNAs, the
L6 myoblast cells were transfected with the Pre-miR(s) followed by
Western Blot analysis to determine the level of the target proteins
compare to the mock treated cells. The miR-23a and miR-29a
transfections led to the 50% down-regulation of SMAD4 level in
L6 cells although there was no miR-23a recognition site for the
SMAD4 39UTR (Fig. 8, 12, I&II). The miR-29a recapitulates the
in vivo data where there is a drastic diminution of SMAD4 level in
rat experimental tissues. The miR-1 and miR-29a target DnaJ-B1
whereas nucleolin is targeted by miR-23 and miR-1 with a
statistical significance (Fig. 12, I&II). We need to be cautious about
the Pre-miR transfection data where there may be an exogenous
binding pressure of the microRNA towards the target. So it is very
important to pursue another reporter-based in vitro experiment to
verify the specificity of the Pre-miR transfection experiment. The
Ambion luciferase-based reporter plasmid (miReport) was used in
cloning the 39UTR of SMAD4 (best candidate) in the MCS of
pMIR-Report plasmid where the translation level of the luciferase
reporter is manipulated by the 39UTR of the target genes. Then
the reporter-based co-transfection was performed using the dual
transfections of LNA-based precursor micro-RNA (25 nM) and
reporter plasmid (2 mg) in 6 well plates harboring L6 myocyte in
triplicates. Fig. 13(I) show the significant decrease of the luciferase
activities for clone-1, 7 and 9, which vary from 40%-50% of the
original vector. This suggests a strong possibility that the cellular
endogenous microRNA(s) may interact with the 39UTR of
SMAD4 to repress luciferase expression, given that there is no
Figure 9. Mimic microRNAs miR-29a and miR-23 up-regulate the glucose transport activities in L6 SKM cell-line as insulin-
independent and dependent manner respectively. A. Pre-miR transient transfection. 25 nM Pre-miRs were transfected in rat L6 cells
according to the protocol as described in method section.
14C-labelled 2-deoxyglucose and
3H-labelled OMe-glucose were used as substrate along
with the non-radioactive substrate (0.15 mM) for glucose transport activity as reversible and irreversible manner respectively. Cytochalasin B is not
being added. B. Pre-miR transfection with Insulin. Same transfection experiments were done with cytochalasin B (10 mM) added in the transport
reaction in presence and absence of 50 nM insulin. Glucose transport assay was performed just (I) before and (II) after adding insulin. (III) Panel was
drawn to see the comparison before and after the insulin addition for each mimic precursor microRNA with respect to the control transport of
14C-
labelled 2-deoxyglucose.
doi:10.1371/journal.pone.0034596.g009
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upstream promoter elements. Then the transfections of precursor
miRNA(s) were performed, along with the plasmid reporter with
or without the 39UTR of SMAD4 gene. The vector controls were
retained as a negative control where the administration of
microRNA inside the cells might bring about luciferase expression
changes without the involvement of the SMAD4 39UTR
interactions. Fig. 13(II) shows the exogenous miR-29a does not
alter the vector luciferase expression upon transfection, but
represses significantly (p=0.02) the SMAD4 39UTR mediated
luciferase expression. Whereas, miR-1 and miR-23a transfections
results in inconclusively because of the effect of microRNA on the
pMIR-Reporter expression alone. But again, the inclusion of the
‘vector alone’ negative control could be erroneous because of the
disparity of the neighboring DNA sequences between the reporter
alone and its SMAD4 39UTR construct. It becomes indecisive of
the mode of action of miR-23a either to be acting as a direct
mediator of gene repression of SMAD4 or targets another protein
mRNA factor(s) that regulate SMAD4 expression. In either way,
mir-23a has a significant effect on SMAD4 gene expression and
has a profound role in insulin-dependent glucose transport process
(Fig. 9, 10, 12). The miR-29a is proven to be the real candidate to
interact with the SMAD4 39UTR and also regulate the glucose
transport activity in L6 cells. Huang S. et al., [67] reported a link
between miR23a and the TGF-b pathway. Stimulation by TGF-b
in Huh7 cells up-regulates miRNA cluster ‘miR-23a,27a,24’
and this up-regulation attenuates the TGF-b pathway. The
39UTR of these mRNAs harbor the miRNA target sites (DnaJ1
contains miR-29a and Nucleolin (C23) contains miR-1 sites) and
this data is supported by the transfections of Pre-miR(s) in L6
myoblast cells (Fig. 12). MiR-1 targets both DnaJ-B1& Nucleolin;
miR-23a target nucleolin & SMAD4 and miR-29a targets DnaJ-
B1 & SMAD4 39UTR. So, miR-29a and miR-23a may directly or
indirectly affect SMAD4 expression. SMAD4 protein level in the
experimental animals was reduced drastically, particularly in
cytosolic and cytoskeletal fractions but not in the nuclear fraction
of SMSP samples (Fig. 6, 7, 11) although there was a trend of
diminishing value by 14%. This suggested that not much change is
expected in the SMAD4-mediated transcription in the male rat
model of IPGR, but only expecting the role of SMAD4 in possible
perturbation of Insulin signaling regulating Glut4 protein
translocation and glucose transport.
Small inhibitory RNA mediated SMAD4 depletion
boosted the glucose transport activity in L6 myoblast-
myocyte cells: SMAD4 acts as a negative regulatory
protein in sk. muscle glucose transport pathway
There are examples where the TGF-b pathway is intrigued for
either miRNA biogenesis including maturation and/or specific
miRNAs target the TGF-b/BMP signaling proteins for biological
activities. The regulation of micro-RNA biogenesis by SMAD
proteins is critical for the vascular smooth muscle cell phenotype
by TGF-b signaling pathways. A novel role of SMAD in
processing the nuclear primary micro-RNA is discussed in the
review of Hata and Davis [68]. It has been reported by other
investigators that SMAD4 has been targeted by many micro-
RNAs, e.g. miR-224 for cell proliferation and function through
TGF-b pathway. Huang S. et al., 2008 [65] published that the
microRNA cluster miR-23a,miR-27a,miR-24 decreases TGF-b
induced tumor suppressive activities in human liver cancer cells
(HCC). In another paper, TGF-b reduced the level of miR-29a
and vice versa. The inhibition of TGF-b by imatinib restores the
level of miR-29a in fibroblast cells [69]. All of these examples
signify that the SMAD-dependent TGF-b pathway is a key target
of micro-RNA function for various broad-ranged biological
activities mediated by miR-23a & 29a. MiR-29a and miR-23a
target SMAD4 to regulate glucose transport in rat skeletal muscle.
It is very important to ask the involvement of SMAD4, in the
glucose transport process in cell culture system. I knock-down the
SMAD4 by small inhibitory RNA w.r.t control where the
scrambled siRNA is used (Fig. 14D). Two different cell types
were used, L6 SKM myoblasts and H9c2 cardiomyocytes for
glucose transport activity. The microRNA(s) 29a and 23a, acting
directly and indirectly respectively on SMAD4 repressing its
glucose transport activities. So, SMAD4 acts like a negative
regulator of glucose transport activity in skeletal muscle. Upon
depletion of SMAD4, at least partially, an increase would be
expected in glucose transport in SKM. Both in sk. muscle
myocytes and cardiomyocytes in Fig. 14A, C respectively, shows
the increase in GTA in absence of insulin (p=0.002 and ,0.05)
by 28% and 16% respectively. Apparently, this effect may be
visualized, although not very drastic, nevertheless, in the metabolic
scenario, this 28% increase of glucose transport activity in muscle
cells carries high significance in the actual context of metabolic
perturbation. In H2c9 cardiomyocytes, the efficiency of glucose
transport is much less than that of L6 cell-line. Fig. 14B
demonstrates that the GTA becomes normalized to the control
cells under the treatment of insulin in absence of SMAD4 protein.
Figure 10. MicroRNA anti-sense inhibitors (miR-29a and miR-
23a) down-regulate the glucose transport activity in insulin-
added condition in L6 cell-line. Ambion-tested specific endogenous
microRNA inhibitors (25 nM) were used in this experiment basically the
same way as mimic transfection experiment (A & B). Only, the standard
radioactivity amount was increased to 7.5 mCi per 12 well plate for both
(I) without insulin and (II) with insulin conditions. Cytochalasin B
(10 mM) was added in the transport reactions.
doi:10.1371/journal.pone.0034596.g010
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the transcription factors, are down-regulated, whereas HAND2 and SMAD4 remain unaltered. Lamin A served as internal control.
doi:10.1371/journal.pone.0034596.g011
Figure 12. SMAD4 is one of the targets for miR-29a and/or miR-23a: Analysis in Cell-line. PremiR transfections (25 nM) of rat L6 myoblast-
myocytes were done and the cell-extracts were subjected to Western Blot analysis for SMAD4, nucleolin and DnaJ-B1 level after 48 hours (I). The
triplicate experiments were run in SDS-PAGE/Western Blot to have statistical significant data (T-test) and expressed as relative intensities (%) (I).
doi:10.1371/journal.pone.0034596.g012
miRNAs Regulate Glucose Transport in Sk. Muscle
PLoS ONE | www.plosone.org 14 April 2012 | Volume 7 | Issue 4 | e34596This suggests that the addition of insulin in L6 cells either
complements the level of SMAD4 transcriptionally or induces the
insulin-signaling proteins that are counteracted by the SMAD4-
mediated inhibition of glucose transport. Unfortunately, at this
point, the extent of glucose transport activity increase in skeletal
muscle tissues in IPGR offspring animals has not been determined.
The phenotypes of the IPGR animals including the metabolic
syndrome, if there is any, are also under investigation. Results
from two different cell-types, skeletal and heart muscles, probably
suggest a universal mode of action of SMAD4 through the
inhibition of target proteins in glucose transport machinery in
skeletal muscle. This is the first report that the TGF-b pathway is
implicated in the skeletal muscle glucose transport function
through a common protein factor, SMAD4 has a tremendous
implication on the involvement of growth inhibitory signaling in
glucose transport process. As there was no significant changes in
the nuclear SMAD4 amount (14.3% trend decrease of p value
0.16), it is very likely that this molecule alters the cytoplasmic
signaling affecting GLUT4 translocation. The upstream events of
SMAD4 will have to be studied in TGF-b pathway for better
clarification and role of this protein for the process. The non-
SMAD TGF-b signaling might also be important to affect the
glucose translocation process in sk. muscle [70]. SMAD4 may be a
very good target of intersection between the cell survival pathway,
such as IGF and growth suppressor pathway TGF-b. The growth-
inhibitory action of TGF-beta 1 on the IGF-I-induced mitogenic
effect has been tested by Mincion G., et al. 2003 [71]. IGF-1 also
inhibits the transcriptional responses of TGF-b by suppressing the
activation of SMAD3 protein in PI3K/AKT dependent way [72].
In our studies, the SMSP (IPGR) male adults express IGFR
significantly (Fig. 5) that might down-regulate the TGF-b pathway
in an unknown mechanism. These demonstrate the cross-talk
ability of these two opposing signaling pathways. In this semi-
calorie starvation model of IPGR, particularly in the male skeletal
muscles, the plethora of molecular evidences, both in vitro and in
vivo, strongly suggested a negative role of the TGF-b pathway
central protein factor, SMAD4, in the normal physiological
function.
Conclusion
As a first step of elucidating skeletal muscle GLUT4 gene-
expression pattern in the IPGR offspring, GLUT4 mRNA went
down in the IPGR female offspring by 35% whereas for male,
remains unaltered. The sharp decrease in GLUT4 gene expression
for female offspring is due to the transcriptional repression because
of the HDAC1/4 recruitment aberration on the upstream
promoter of GLUT4 (MEF2 and MyoD specified) and subsequent
changes in the histone-modifications directed to the less transcrip-
tion of this gene. On the contrary, it was found that the membrane
GLUT4 is localized more in the male IPGR samples (Fig. 5) in
contrast to the female. This intrigued me to investigate the other
genetic factors that affect the expression status of the sk. muscle.
While investigating the epigenetic marker status of the male
counterparts, I have decided to explore the microRNA status of
the male counterparts that might be targeting the signaling
pathways leading to the regulation and fine-tuning of glucose
Figure 13. Reporter analysis for microRNA targeting SMAD4 39UTR. The 39UTR was cloned in luciferase based pMIR-reporter of Ambion for
reporter analysis of microRNA binding sites in its UTR. Plasmid was transfected in presence and absence of precursor microRNAs; 29a, 1 and 23a
mimic (25 nM). (I) 3 clones were transfected separately w.r.t. vector without SMAD4 39UTR. (II) Pre-miR-29a, (III) Pre-miR-23a and (IV) Pre-miR-1
precursors were transfected along with either SMAD4-39UTR clone or empty vector. Luciferase light units (RLU) were measured in luminometer and
expressed as per OD(595) protein measured by Bradford. Triplicate was assayed and expressed as statistical significance by T-test.
doi:10.1371/journal.pone.0034596.g013
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starved conditions. MiR-29a and 23a turned out to be important
for efficient glucose transport activity. Both of them target a very
critical signaling factor in the TGF-b pathway, called SMAD4,
either directly binding to its 39UTR or indirectly with other factors
respectively. This finding postulates that under normal physiolog-
ical condition, these microRNAs manipulate SMAD4 expression
in the translational level, so that the firing of the glucose transport
remains in its basal level in the sk. muscle. Now, on starvation
stress, based on the semi-calorie food restriction model in rat, these
microRNAs are over-expressed that repressed this co-SMAD’s
expression, probably transiently, resulting in the activation of
GLUT4-mediated glucose transport. There is a possibility of
another group of microRNAs which are under-expressed in the
experimental SMSP samples (Fig. 2) and those could activate the
glucose transport inside the cells, by targeting plausible activators
of insulin and/or IGF signaling pathways yet to be determined.
So, the systematic isolation of microRNAs in the IPGR skeletal
muscles, both in male and female samples, would reveal a number
of known and unknown protein factors regulating the influx of
glucose in skeletal muscles. The identification and targeting of
positive and negative regulatory proteins through microRNAs
would reveal the complicated metabolic cross-talks among major
cell-signaling pathways, where the glucose transporters demand
the central focus of studies.
In summary, we have provided strong evidence of the role and
plasticity of specific microRNA to manipulate gene expression
leading to an alternation of skeletal muscle glucose transport. The
miR-29a and miR-23a are two such micro-RNAs identified that
modulate the glucose transport pathway in vitro as a general and
insulin-dependent manner. A critical target regulatory protein has
been identified and appears to function as a negative regulatory
element in the glucose transport system. This target protein
SMAD4, whose 39UTR contains the binding sites for miR-29a,
let7a and miR-1 that are over-expressed in the IPGR male sk.
muscle samples. Overall, this paper opens up a new field of
investigation in glucose transport pathway regulated by a group of
microRNAs operating under starvation stress or in certain
physiological conditions. As expected, under stress conditions,
including starvation, aberration of the expression of specific
microRNAs could alter the metabolic status of the muscle cells,
and may lead to pathological conditions such as metabolic
syndromes.
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